Matches in SemOpenAlex for { <https://semopenalex.org/work/W2363480212> ?p ?o ?g. }
- W2363480212 endingPage "e1002015" @default.
- W2363480212 startingPage "e1002015" @default.
- W2363480212 abstract "Background High rates of patient attrition from care between HIV testing and antiretroviral therapy (ART) initiation have been documented in sub-Saharan Africa, contributing to persistently low CD4 cell counts at treatment initiation. One reason for this is that starting ART in many countries is a lengthy and burdensome process, imposing long waits and multiple clinic visits on patients. We estimated the effect on uptake of ART and viral suppression of an accelerated initiation algorithm that allowed treatment-eligible patients to be dispensed their first supply of antiretroviral medications on the day of their first HIV-related clinic visit. Methods and Findings RapIT (Rapid Initiation of Treatment) was an unblinded randomized controlled trial of single-visit ART initiation in two public sector clinics in South Africa, a primary health clinic (PHC) and a hospital-based HIV clinic. Adult (≥18 y old), non-pregnant patients receiving a positive HIV test or first treatment-eligible CD4 count were randomized to standard or rapid initiation. Patients in the rapid-initiation arm of the study (“rapid arm”) received a point-of-care (POC) CD4 count if needed; those who were ART-eligible received a POC tuberculosis (TB) test if symptomatic, POC blood tests, physical exam, education, counseling, and antiretroviral (ARV) dispensing. Patients in the standard-initiation arm of the study (“standard arm”) followed standard clinic procedures (three to five additional clinic visits over 2–4 wk prior to ARV dispensing). Follow up was by record review only. The primary outcome was viral suppression, defined as initiated, retained in care, and suppressed (≤400 copies/ml) within 10 mo of study enrollment. Secondary outcomes included initiation of ART ≤90 d of study enrollment, retention in care, time to ART initiation, patient-level predictors of primary outcomes, prevalence of TB symptoms, and the feasibility and acceptability of the intervention. A survival analysis was conducted comparing attrition from care after ART initiation between the groups among those who initiated within 90 d. Three hundred and seventy-seven patients were enrolled in the study between May 8, 2013 and August 29, 2014 (median CD4 count 210 cells/mm3). In the rapid arm, 119/187 patients (64%) initiated treatment and were virally suppressed at 10 mo, compared to 96/190 (51%) in the standard arm (relative risk [RR] 1.26 [1.05–1.50]). In the rapid arm 182/187 (97%) initiated ART ≤90 d, compared to 136/190 (72%) in the standard arm (RR 1.36, 95% confidence interval [CI], 1.24–1.49). Among 318 patients who did initiate ART within 90 d, the hazard of attrition within the first 10 mo did not differ between the treatment arms (hazard ratio [HR] 1.06; 95% CI 0.61–1.84). The study was limited by the small number of sites and small sample size, and the generalizability of the results to other settings and to non-research conditions is uncertain. Conclusions Offering single-visit ART initiation to adult patients in South Africa increased uptake of ART by 36% and viral suppression by 26%. This intervention should be considered for adoption in the public sector in Africa. Trial Registration ClinicalTrials.gov NCT01710397, and South African National Clinical Trials Register DOH-27-0213-4177." @default.
- W2363480212 created "2016-06-24" @default.
- W2363480212 creator A5009058080 @default.
- W2363480212 creator A5010315274 @default.
- W2363480212 creator A5011149711 @default.
- W2363480212 creator A5011677746 @default.
- W2363480212 creator A5028830610 @default.
- W2363480212 creator A5038337241 @default.
- W2363480212 creator A5049688605 @default.
- W2363480212 creator A5051991963 @default.
- W2363480212 creator A5058631355 @default.
- W2363480212 creator A5066253506 @default.
- W2363480212 creator A5074213191 @default.
- W2363480212 date "2016-05-10" @default.
- W2363480212 modified "2023-10-16" @default.
- W2363480212 title "Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial" @default.
- W2363480212 cites W1502476404 @default.
- W2363480212 cites W1605629550 @default.
- W2363480212 cites W1694605733 @default.
- W2363480212 cites W1988650326 @default.
- W2363480212 cites W1995759613 @default.
- W2363480212 cites W2011213235 @default.
- W2363480212 cites W2020067933 @default.
- W2363480212 cites W2025415062 @default.
- W2363480212 cites W2034070668 @default.
- W2363480212 cites W2034630867 @default.
- W2363480212 cites W2047825669 @default.
- W2363480212 cites W2048986863 @default.
- W2363480212 cites W2054219015 @default.
- W2363480212 cites W2073620484 @default.
- W2363480212 cites W2102545142 @default.
- W2363480212 cites W2106715525 @default.
- W2363480212 cites W2126078440 @default.
- W2363480212 cites W2134277905 @default.
- W2363480212 cites W2137576580 @default.
- W2363480212 cites W2141741448 @default.
- W2363480212 cites W2144686010 @default.
- W2363480212 cites W2161477336 @default.
- W2363480212 cites W2238552371 @default.
- W2363480212 doi "https://doi.org/10.1371/journal.pmed.1002015" @default.
- W2363480212 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4892484" @default.
- W2363480212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27258028" @default.
- W2363480212 hasPublicationYear "2016" @default.
- W2363480212 type Work @default.
- W2363480212 sameAs 2363480212 @default.
- W2363480212 citedByCount "219" @default.
- W2363480212 countsByYear W23634802122016 @default.
- W2363480212 countsByYear W23634802122017 @default.
- W2363480212 countsByYear W23634802122018 @default.
- W2363480212 countsByYear W23634802122019 @default.
- W2363480212 countsByYear W23634802122020 @default.
- W2363480212 countsByYear W23634802122021 @default.
- W2363480212 countsByYear W23634802122022 @default.
- W2363480212 countsByYear W23634802122023 @default.
- W2363480212 crossrefType "journal-article" @default.
- W2363480212 hasAuthorship W2363480212A5009058080 @default.
- W2363480212 hasAuthorship W2363480212A5010315274 @default.
- W2363480212 hasAuthorship W2363480212A5011149711 @default.
- W2363480212 hasAuthorship W2363480212A5011677746 @default.
- W2363480212 hasAuthorship W2363480212A5028830610 @default.
- W2363480212 hasAuthorship W2363480212A5038337241 @default.
- W2363480212 hasAuthorship W2363480212A5049688605 @default.
- W2363480212 hasAuthorship W2363480212A5051991963 @default.
- W2363480212 hasAuthorship W2363480212A5058631355 @default.
- W2363480212 hasAuthorship W2363480212A5066253506 @default.
- W2363480212 hasAuthorship W2363480212A5074213191 @default.
- W2363480212 hasBestOaLocation W23634802121 @default.
- W2363480212 hasConcept C126322002 @default.
- W2363480212 hasConcept C142462285 @default.
- W2363480212 hasConcept C168563851 @default.
- W2363480212 hasConcept C1862650 @default.
- W2363480212 hasConcept C187212893 @default.
- W2363480212 hasConcept C2993143319 @default.
- W2363480212 hasConcept C3013748606 @default.
- W2363480212 hasConcept C512399662 @default.
- W2363480212 hasConcept C71924100 @default.
- W2363480212 hasConceptScore W2363480212C126322002 @default.
- W2363480212 hasConceptScore W2363480212C142462285 @default.
- W2363480212 hasConceptScore W2363480212C168563851 @default.
- W2363480212 hasConceptScore W2363480212C1862650 @default.
- W2363480212 hasConceptScore W2363480212C187212893 @default.
- W2363480212 hasConceptScore W2363480212C2993143319 @default.
- W2363480212 hasConceptScore W2363480212C3013748606 @default.
- W2363480212 hasConceptScore W2363480212C512399662 @default.
- W2363480212 hasConceptScore W2363480212C71924100 @default.
- W2363480212 hasFunder F4320337355 @default.
- W2363480212 hasIssue "5" @default.
- W2363480212 hasLocation W23634802121 @default.
- W2363480212 hasLocation W23634802122 @default.
- W2363480212 hasLocation W23634802123 @default.
- W2363480212 hasLocation W23634802124 @default.
- W2363480212 hasOpenAccess W2363480212 @default.
- W2363480212 hasPrimaryLocation W23634802121 @default.
- W2363480212 hasRelatedWork W2036827172 @default.
- W2363480212 hasRelatedWork W2055280854 @default.
- W2363480212 hasRelatedWork W2087771447 @default.
- W2363480212 hasRelatedWork W2334605091 @default.
- W2363480212 hasRelatedWork W2355769538 @default.